Oxford Asset Management’s iRadimed IRMD Stock Holding History

Oxford Asset Management’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-24,061	Closed	-$563K	–	746
2019 Q4	$563K	Buy	+24,061	New	+$562K	0.02%	1184
2019 Q1	–	Sell	-12,247	Closed	-$300K	–	1818
2018 Q4	$300K	Sell	12,247 -40,384	-77%	-$1.09M	0.01%	1404
2018 Q3	$1.94M	Buy	+52,631	New	+$1.42M	0.04%	678
2018 Q1	–	Sell	-21,210	Closed	-$323K	–	1749
2017 Q4	$323K	Sell	21,210 -13,677	-39%	-$174K	0.01%	1315
2017 Q3	$337K	Sell	34,887 -16,431	-32%	-$156K	0.01%	1314
2017 Q2	$441K	Sell	51,318 -14,345	-22%	-$122K	0.01%	1149
2017 Q1	$584K	Buy	65,663 +30,238	+85%	+$280K	0.01%	1002
2016 Q4	$393K	Buy	35,425 +23,823	+205%	+$256K	0.01%	625
2016 Q3	$197K	Sell	11,602 -32,140	-73%	-$595K	0.01%	708
2016 Q2	$952K	Buy	43,742 +15,247	+54%	+$274K	0.03%	495
2016 Q1	$546K	Buy	28,495 +8,234	+41%	+$158K	0.02%	599
2015 Q4	$565K	Buy	+20,261	New	+$573K	0.01%	651

Other funds holding IRMD

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

RCMC

RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Oxford Asset Management's IRMD Position: Q1 2020 in Review

Oxford Asset Management sold out of iRadimed (IRMD) in Q1 2020, closing a stake of 24,061 shares — an estimated $563K sold.

Oxford Asset Management first reported a position in IRMD in Q4 2015 and held it in 12 quarters. The position peaked at $1.94M in Q3 2018. 69 funds tracked by Wall St. Rank hold IRMD as of Q1 2020.

Oxford Asset Management reported no remaining iRadimed position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 24,061 iRadimed shares in Q1 2020, an estimated $563K.
Oxford Asset Management first reported a position in iRadimed in Q4 2015 and held it in 12 quarters.
Oxford Asset Management's iRadimed position peaked at $1.94M in Q3 2018.
69 funds tracked by Wall St. Rank held iRadimed as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.